Document Detail


Tamoxifen retinopathy. A case report.
MedLine Citation:
PMID:  2131119     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Tamoxifen is one of the most effective anti-estrogens for breast carcinoma therapy and has been used since 1971. Side effects are not frequent, but some ophthalmologic complications have already been described such as retinopathy, keratopathy and optic neuritis. The authors report a case of retinopathy occurring after a period of 7 years (205 g total doses). They give a review of the literature, with the ophthalmological and functional aspects of the retinopathy.
Authors:
R H Costa; M R Dhooge; F Van Wing; A F De Rouck
Related Documents :
1987659 - The synergism of atropine and the cholinesterase reactivator hi-6 in counteracting leth...
18819779 - Zolpidem-induced amnesia and somnambulism: rare occurrences?
17039659 - Etanercept responsive acrodermatitis continua of hallopeau: is a pattern developing?
22929039 - Larval morphology, development and forensic importance of synthesiomyia nudiseta (dipte...
23356699 - Rameses publication standards: meta-narrative reviews.
17057269 - Oxybutynin: dry days for patients with hyperhidrosis.
8688659 - Interruption of breast feeding caused by the presence of neonatal teeth.
20409409 - Multiple pilomatricomas: case presentation and review of the literature.
20494549 - Intravenous lobular capillary hemangioma.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Bulletin de la Société belge d'ophtalmologie     Volume:  238     ISSN:  0081-0746     ISO Abbreviation:  Bull Soc Belge Ophtalmol     Publication Date:  1990  
Date Detail:
Created Date:  1991-12-03     Completed Date:  1991-12-03     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  7505353     Medline TA:  Bull Soc Belge Ophtalmol     Country:  BELGIUM    
Other Details:
Languages:  eng     Pagination:  161-8     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology, University of Ghent.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Breast Neoplasms / drug therapy
Female
Humans
Macula Lutea / drug effects
Middle Aged
Retinal Diseases / chemically induced*
Tamoxifen / adverse effects*,  therapeutic use
Time Factors
Chemical
Reg. No./Substance:
10540-29-1/Tamoxifen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment of chronic macular oedema with low dosage acetazolamide.
Next Document:  Lacrimal conjunctivitis.